* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
fall in
quarterly revenue when it reports results on January 31
(estimated) for the period ending December 31 2024
* The Atlanta Georgia-based company is expected to report a
28.6% decrease in revenue to $63.627 million from $89.17 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.The company's guidance on November 6 2024,
for the period ended December 31, was for revenue between $62.00
million and $67.00 million. (SAL basis is Total Revenue)
* LSEG's mean analyst estimate for Cardlytics Inc is for a
loss
of 18 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$4.00, above its last closing price of $3.44.
The company's guidance on November 6 2024 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 62 million and -1
million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2024 -0.25 -0.24 -0.15 Beat 38
Jun. 30 2024 -0.11 -0.13 -0.15 Missed -19
Mar. 31 2024 -0.10 -0.11 -0.09 Beat 18.2
Dec. 31 2023 0.15 0.12 0.14 Beat 16.7
Sep. -0.01 -0.01 0.01 Beat 200
30 2023
Jun. 30 2023 -0.35 -0.35 -0.24 Beat 32.1
Mar. 31 2023 -0.56 -0.56 -0.25 Beat 55.7
Dec. 31 2022 -0.46 -0.46 -0.29 Beat 37.5
This summary was machine generated January 29 at 13:33 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)